Membranous Nephropathy - PLA2R Induced
5 clinical trials · Condition
◉ Watch Membranous Nephropathy - PLA2R Induced
| Record | Firm | Date |
|---|---|---|
| Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study (NCT07163611) | Radboud University Medical Center | 2025-10-01 |
| The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases (NCT06285279) | Nanjing University School of Medicine | 2024-03-04 |
| Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy (NCT05894512) | Istanbul University | 2023-06-01 |
| Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay) (NCT05861869) | Zhejiang Biostar Biotechnology Co. | 2023-05-04 |
| Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy (NCT05679336) | St. Petersburg State Pavlov Medical University | 2018-05-01 |
Track Membranous Nephropathy - PLA2R Induced automatically
Every clearance here is in the API, with alerts when new ones post.